Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics.

Wang S, Liu Y, Liu Q, Zhang M, Bai X, Li X, Li X, Jin C, Sun X, Xu J, Zhao X, Fu J, Wang H.

Open source

DOI
10.1016/j.canlet.2026.218810
Published
2026-09-01
Container
Cancer Lett
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.canlet.2026.218810,
  title = {Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics.},
  author = {Wang S and  Liu Y and  Liu Q and  Zhang M and  Bai X and  Li X and  Li X and  Jin C and  Sun X and  Xu J and  Zhao X and  Fu J and  Wang H.},
  year = {2026},
  journal = {Cancer Lett},
  doi = {10.1016/j.canlet.2026.218810},
  url = {https://doi.org/10.1016/j.canlet.2026.218810}
}

RIS

TY  - JOUR
TI  - Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics.
AU  - Wang S
AU  -  Liu Y
AU  -  Liu Q
AU  -  Zhang M
AU  -  Bai X
AU  -  Li X
AU  -  Li X
AU  -  Jin C
AU  -  Sun X
AU  -  Xu J
AU  -  Zhao X
AU  -  Fu J
AU  -  Wang H.
PY  - 2026
JO  - Cancer Lett
DO  - 10.1016/j.canlet.2026.218810
UR  - https://doi.org/10.1016/j.canlet.2026.218810
ER  - 

APA

S, W., Y, L., Q, L., M, Z., X, B., X, L., X, L., C, J., X, S., J, X., X, Z., J, F., & H., W. (2026). Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics.. Cancer Lett. https://doi.org/10.1016/j.canlet.2026.218810

Source records